For the final installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Life Sciences Europe, Gemma Pfister, to focus on the Life Sciences industry – the trends most impacting the pharmaceutical and biotech sectors.
To learn more about Vynamic’s overall 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/
Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, biotech, Inflation Reduction Act, product launch, direct-to-consumer, pharmacy, integrated delivery networks
Panel – Karen Baldry, Gemma Pfister, Jen Burke
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
In this episode, Ollie, Jack, and Nathan discuss the rise of Barcelona as a hotbed for Digital Health Innovation. They...
Listen nowHealth industry 2025: Navigating economic shifts, tech advances, new regulations, and innovations in Life Sciences, Health Services, & MedTech.
Read moreLife science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more